In this podcast, you will hear a panel discussion moderated by John Merhige, Credence MedSystems from the 2022 PODD Conference regarding implementable guidance for both pharma companies and delivery companies looking to partner including:

The similarities and differences when collaborating on device vs. formulation delivery technologies
Different pathways and mechanisms available for different stages of innovative technology, from pure innovation to proven technologies
Key criteria Pharma is looking for in the technology and the innovator company AND advice on how to present to Pharma
The roles of procurement, business development and other functional groups in scoping, structuring deals and negotiation

Panelists include:

Deborah Bitterfield, PhD, Lindy Biosciences
Michael Cucolo, Bristol-Myers Squibb
Vincent Ling, PhD, Takeda
Sarah Tao, PhD, Sanofi Partnering

To learn more about the PODD Conference, please visit PODDConference.com.

Advice for Partnering Between Innovator Drug Delivery Companies and Big Pharma

Share

Embed